T-cell Brazil: Prospective Collection of Data in T-cell Lymphomas Patients
NCT03207789 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2017-07-05
Summary
The designed study follows up on the previous one by the international T-cell project (Bellei et al,, 2012) and its purpose is to verify whether a prospective collection of data would permit access to more accurate information permitting a better definition of prognosis and investigation of more adequate treatment strategies for these neoplasms.
The analysis of patients distributed in all five macro regions of the country and a comparison among them will provide a real picture of the disease in Brazil, limiting the bias probably found in the previous projects.
Conditions
- T-cell Lymphoma
- NK-Cell Lymphoma
- T-cell Lymphoma Adults
Sponsors & Collaborators
- collaborator INDUSTRY
-
Grupo de Estudos Multicentricos em Onco-Hematologia
lead NETWORK
Principal Investigators
-
Eliana CM Miranda, M.Ed.; Ph.D. · Grupo de Estudos Multicentricos em Onco-Hematologia
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-01-01
- Primary Completion
- 2017-06-01
- Completion
- 2020-12-31
More Related Trials
-
Observational Controlled Clinical Trials, on Adult Patients With T-lymphoblastic Lymphoma Treated With Intensive Chemo/Radiotherapy or Intensive Chemotherapy Followed by Transplant. Evaluation of Clinical, Anatomy -Pathological Parameters
NCT00882011 ·Status: UNKNOWN
-
Circulating Tumor DNA in Peripheral T-cell Lymphomas
NCT06362148 ·Status: ACTIVE_NOT_RECRUITING
-
A Retrospective Study of Clinical, Phenotypic and Genetic Factors of Peripheral T-Cell Lymphomas
NCT02788916 ·Status: COMPLETED
-
Minimal Residual Disease in Peripheral T-cell Lymphoma
NCT03297697 ·Status: COMPLETED
-
Radiomics and Metabolomics in the Follow-up of CAR T-cells for Refractory or Relapsed Non-Hodgkin's Lymphoma
NCT05422521 ·Status: RECRUITING ·Phase: NA
-
T-Cell Project: Epidemiologic Component
NCT00705809 ·Status: COMPLETED
-
A Registry for People With T-cell Lymphoma
NCT05978141 ·Status: RECRUITING
-
A Study of Improving the Efficacy of Treatment in High Risk T Cell Lymphoma Patients
NCT01788137 ·Status: UNKNOWN ·Phase: PHASE3
-
Efficacy of a Treatment With CHOP and Lenalidomide in First Line in Angioimmunoblastic T-cell Lymphoma (AITL)
NCT01553786 ·Status: COMPLETED ·Phase: PHASE2
-
Brazilian Network for Lymphoma Registry
NCT02265497 ·Status: RECRUITING
-
Correlation Analysis of T-lymphocyte Subsets and Prognosis in Autologous Stem Cell Transplantation (ASCT) for Lymphoma
NCT03283111 ·Status: UNKNOWN ·Phase: NA
-
Mechanism of Resistance to GNC-038 in Relapsed and Refractory Diffuse Large B-cell Lymphoma
NCT05189782 ·Status: UNKNOWN
-
Identification of New Immune Factors Specific of Relapse in Childhood B Lineage Acute Lymphoblastic Leukemia
NCT02618109 ·Status: TERMINATED ·Phase: PHASE4
-
Brazilian Prospective Hodgkin Lymphoma Registry
NCT02589548 ·Status: UNKNOWN
-
An Italian Multicentric Retrospective Observational Study to Assess Effectiveness and Safety of the Combination of Tafasitamab and Lenalidomide in Diffuse Large B-cell Lymphoma Patients Treated Under Named Patient Program
NCT06782789 ·Status: RECRUITING
-
Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry
NCT01110733 ·Status: COMPLETED
-
A Global Study of the PETAL Consortium
NCT06067347 ·Status: RECRUITING
-
Intensive Chemo-immunotherapy as First Line Treatment in Adult Patients With Peripheral T- Cell Lymphoma
NCT01679860 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy Plus PD-1 Monoclonal Antibody in the Treatment of Refractory or Relapsed Peripheral T-cell Lymphoma.
NCT05821192 ·Status: UNKNOWN ·Phase: NA
-
Allo-HSCT Vs. Auto-HSCT for PTCL Patients With PR After First-line Systemic Therapy : A Prospective, Multicenter, Cohort Study-(T-START-PR)
NCT07253129 ·Status: RECRUITING
-
Brazilian Reality in the Diagnosis and Treatment of Diffuse Large B Cell Lymphoma - BRA-DLBCL
NCT05958134 ·Status: COMPLETED
-
MB-105 in Patients With CD5 Positive T-cell Lymphoma
NCT06534060 ·Status: RECRUITING ·Phase: PHASE2
-
Systemic Therapies in the Treatment of Cutaneous T-cell Lymphoma
NCT06588868 ·Status: RECRUITING
-
Italian Multicenter Retrospective Observational Study on Transformed Lymphomas
NCT02927756 ·Status: UNKNOWN
-
Natural Killer Cells Function in Patients With Chronic Lymphocytic Leukemia
NCT00934986 ·Status: COMPLETED ·Phase: NA